Cargando…
Our experience in using magnetic resonance imaging (MRI) as an adjunct to mammography and ultrasound in assessing response to neoadjuvant chemotherapy
Autores principales: | Dall, B, Parkin, G, Dodwell, D, Lane, S, Wilson, D, Jervis, S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3300454/ http://dx.doi.org/10.1186/bcr480 |
Ejemplares similares
-
Breast magnetic resonance imaging (MRI) – common pitfalls: a pictorial representation
por: Dall, B, et al.
Publicado: (2002) -
Neoadjuvant chemotherapy in locally advanced gastric adenocarcinoma: our experience in the elderly
por: Bugiantella, W, et al.
Publicado: (2009) -
Contrast-Enhanced Mammography (CEM) for Detecting Residual Disease after Neoadjuvant Chemotherapy: A Comparison with Breast Magnetic Resonance Imaging (MRI)
por: Barra, Filipe Ramos, et al.
Publicado: (2018) -
Contrast-enhanced spectral mammography in neoadjuvant chemotherapy monitoring: a comparison with breast magnetic resonance imaging
por: Iotti, Valentina, et al.
Publicado: (2017) -
Epidermoid cyst of the breast: Mammography, ultrasound, MRI
por: Wynne, Elisabeth, et al.
Publicado: (2015)